The global bioprocess validation market size is projected to reach USD 842.5 million by 2030, at a CAGR of 9.10% from 2023 to 2030. Bioprocess validation is the process of documentation of all the stages, activities and procedures of the bioproduct formation. This documentation complied with the EMEA and US FDA guidelines of cGMP. It aims to deliver standard, quality, and safe manufacturing of bioproducts. The process has a wide range of applications in drug discovery, therapeutics development, and biosimilar development. Precise analysis of active pharmaceutical ingredients and the removal of contaminants such as endotoxins and, bacteria during drug development are the most crucial step of bioprocess validations.
There is a surge in demand for the in-house as well as outsourcing of the validation process, which drives the global market. Trace contaminants are formed during the production and manufacturing process of bio-products. This is due to the presence of extractable and leachables, which can cause potential hazards to consumers. This can be a major restraining factor, which can hamper the market growth. Moreover, biopharmaceutical and biotechnology industries focusing on low manufacturing costs with higher yields of the products create lucrative opportunities for market growth. The major challenge faced by the key players and bio manufacturers is the approval of novel therapies to validate drug and therapeutics development by the government and regulatory agencies.
COVID-19 has had a positive impact on the global market as the R&D sector and the development of vaccines and therapeutics have flourished. Moreover, increasing demand for the safety and quality cGMP-approved vaccines to treat the COVID-19 virus has led to an increase in the mergers and, partnerships among the market key players for enhancing the upstream and downstream process for delivering efficient bioproducts. An effective validation process not just ensures the quality and safety but also the efficacy of the product. Moreover, during the post-COVID era, most of the biopharmaceutical industries, suppliers, and service providers have increased their pandemic-related research, development, and manufacturing of biosimilars, thus propelling the market.
The increasing CDMOs, bioprocess outsourcing services, stringent government regulations, and guidelines for developing safe and quality products propel the global bioprocess validation industry. Moreover, an increase in the number of clinical trials to deliver impurity-free biosimilars and drugs for the treatment of chronic diseases such as cancer, diabetes, and arthritis boosts the market. In addition to these leading advancements in the life sciences tools and automated systems for the bioprocess, methods boost industry growth.
There is a surge in demand for the in-house as well as outsourcing of the validation process, which drives the global market. Trace contaminants are formed during the production and manufacturing process of bio-products. This is due to the presence of extractable and leachables, which can cause potential hazards to consumers. This can be a major restraining factor, which can hamper the market growth. Moreover, biopharmaceutical and biotechnology industries focusing on low manufacturing costs with higher yields of the products create lucrative opportunities for market growth. The major challenge faced by the key players and bio manufacturers is the approval of novel therapies to validate drug and therapeutics development by the government and regulatory agencies.
COVID-19 has had a positive impact on the global market as the R&D sector and the development of vaccines and therapeutics have flourished. Moreover, increasing demand for the safety and quality cGMP-approved vaccines to treat the COVID-19 virus has led to an increase in the mergers and, partnerships among the market key players for enhancing the upstream and downstream process for delivering efficient bioproducts. An effective validation process not just ensures the quality and safety but also the efficacy of the product. Moreover, during the post-COVID era, most of the biopharmaceutical industries, suppliers, and service providers have increased their pandemic-related research, development, and manufacturing of biosimilars, thus propelling the market.
The increasing CDMOs, bioprocess outsourcing services, stringent government regulations, and guidelines for developing safe and quality products propel the global bioprocess validation industry. Moreover, an increase in the number of clinical trials to deliver impurity-free biosimilars and drugs for the treatment of chronic diseases such as cancer, diabetes, and arthritis boosts the market. In addition to these leading advancements in the life sciences tools and automated systems for the bioprocess, methods boost industry growth.
Bioprocess Validation Market Report Highlights
- The bioprocess residuals testing segment dominated the market with the largest market share of 28.65% in 2022. The increases in the demand for impurity-free bio-products by pharmaceutical, biopharmaceutical, and biotechnology industries and enhancing drug discovery and therapeutics development process will drive the segment to grow in the upcoming forecast.
- By stage segment, the continued process verification segment held the largest share of 42.3% in 2022. This is due to the increasing use and availability of automation facilities for continued process verification, which drives the segment to account for the largest share.
- By mode segment, the outsourced segment dominated the market in 2022. The presence of increased bioprocess validation outsourcing testing services by the majority of the critical players propels the market to account for a large share of this segment.
- North America held the largest share of 38.93% in 2022, due to the presence of an established healthcare sector and key players such as Thermo Fisher Scientific, Inc.; Danaher Corporation; and others in the region.
Table of Contents
Chapter 1 Research Methodology1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Bioprocess Validation Market Variables, Trends, & Scope
4.1 Bioprocess Validation Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Increase In The Number Of Clinical Trials For Vaccine Development
4.4.2 Rise In R&D Expenditure
4.5 Market Restraint Analysis
4.5.1 Issues Related To Extractables & Leachables
4.5.2 High Cost Of The Advanced Technology
4.6 Porter’s Five Forces Analysis
4.7 Swot Analysis
4.8 Covid-19 Impact Analysis
Chapter 5 Bioprocess Validation Market - Segment Analysis, By Testing Type, 2018 - 2030 (USD Million)
5.1 Global Bioprocess Validation Market: Testing Type Movement Analysis
5.2 Extractable & Leachables Testing
5.2.1 Extractables & Leachables Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Bioprocess Residuals Testing
5.3.1 Bioprocess Residuals Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Viral Clearance Testing
5.4.1 Viral Clearance Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Filtration & Fermentation Systems Testing
5.5.1 Filtration & Fermentation Systems Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Bioprocess Validation Market - Segment Analysis, By Stage, 2018 - 2030 (USD Million)
6.1 Global Bioprocess Validation Market: Stage Movement Analysis
6.2 Process Design
6.2.1 Process Design Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Process Qualification
6.3.1 Process Qualification Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Continued Process Verification
6.4.1 Continued Process Verification Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Bioprocess Validation Market- Segment Analysis, By Mode, 2018 - 2030 (USD Million)
7.1 Bioprocess Validation Market: Mode Movement Analysis
7.2 In House
7.2.1 In-House Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Outsourced
7.3.1 Outsourced Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Bioprocess Validation Market: - Segment Analysis, By Region, 2018 - 2030 (USD Million)
8.1 Bioprocess Validation Market: Regional Movement Analysis
8.2 North America
8.2.1 Swot Analysis
8.2.1.1 North America Bioprocess Validation Market, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 U.S. Bioprocess Validation Market, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Canada Bioprocess Validation Market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Swot Analysis
8.3.1.1 Europe Bioprocess Validation Market Estimates And Forecast, 2018-2030, (USD Million)
8.3.2 Uk
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Germany Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 France Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Uk Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Italy Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Spain Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Denmark Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Sweden Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Norway Bioprocess Validation Market, 2018-2030, (USD Million)
8.3.10 Rest Of Europe
8.3.10.1 Key Country Dynamics
8.3.10.2 Competitive Scenario
8.3.10.3 Rest Of Europe Bioprocess Validation Market Estimates And Forecast, 2018-2030 (USD Million)
8.4 Asia Pacific
8.4.1 Swot Analysis
8.4.1.1 Asia Pacific Bioprocess Validation, 2018-2030, (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Japan Bioprocess Validation Market, 2018-2030, (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 China Bioprocess Validation Market, 2018-2030, (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 India Bioprocess Validation Market, 2018-2030, (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Australia Bioprocess Validation Market, 2018-2030, (USD Million)
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 South Korea Bioprocess Validation Market, 2018-2030, (USD Million)
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Thailand Bioprocess Validation Market, 2018-2030, (USD Million)
8.4.8 Rest Of Asia Pacific
8.4.8.1 Key Country Dynamics
8.4.8.2 Competitive Scenario
8.4.8.3 Rest Of Asia Pacific Bioprocess Validation Market, 2018-2030 (USD Million)
8.5 Latin America
8.5.1 Swot Analysis
8.5.1.1 Latin America Bioprocess Validation Market, 2018-2030, (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Brazil Bioprocess Validation Market, 2018-2030, (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Mexico Bioprocess Validation Market, 2018-2030, (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Argentina Bioprocess Validation Market, 2018-2030, (USD Million)
8.5.5 Rest Of Latin America
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Rest Of Latin America Bioprocess Validation Market, 2018-2030 (USD Million)
8.6 Middle East & Africa (Mea)
8.6.1 Swot Analysis
8.6.1.1 Mea Bioprocess Validation Market Estimates And Forecast, 2018-2030, (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 South Africa Bioprocess Validation Market Estimates And Forecast, 2018-2030, (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Saudi Arabia Bioprocess Validation Market Estimates And Forecast, 2018-2030 (USD Million)
8.6.4 Uae
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Uae Bioprocess Validation Market Estimates And Forecast, 2018-2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive Scenario
8.6.5.3 Kuwait Bioprocess Validation Market Estimates And Forecast, 2018-2030 (USD Million)
8.6.6 Rest of MEA
8.6.6.1 Key Country Dynamics
8.6.6.2 Competitive Scenario
8.6.6.3 Rest Of Mea Bioprocess Validation Estimates And Forecast, 2018-2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Participant’s Overview
9.1.1 Eurofins Scientific, Inc.
9.1.2 Sartorius Ag
9.1.3 Thermo Fisher Scientific Inc.
9.1.4 Lonza
9.1.5 Danaher Corporation
9.1.6 Charles River Laboratories
9.1.7 Sgs S.A.
9.1.8 Toxicon Corporation
9.1.9 Epigenomics Ag
9.1.10 Cobetter Filtration Equipment Co., Ltd.
9.2 Financial Performance
9.3 Participant Categorization
9.3.1 Market Leaders
9.3.1.1 Bioprocess Validation Market Share Analysis, 2022
9.3.2 Strategy Mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Stage/Service Launch
9.3.2.5 Partnerships
9.3.2.6 Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 4 Global bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 5 Global bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 6 North America bioprocess validation market by country, 2018 - 2030 (USD million)
Table 7 North America bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 8 North America bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 9 North America bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 10 U.S. bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 11 U.S. bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 12 U.S. bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 13 Canada bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 14 Canada bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 15 Canada bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 16 Europe bioprocess validation market by country, 2018 - 2030 (USD million)
Table 17 Europe bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 18 Europe bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 19 Europe bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 20 UK bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 21 UK bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 22 UK bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 23 Germany bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 24 Germany bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 25 Germany bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 26 France bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 27 France bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 28 France bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 29 Italy bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 30 Italy bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 31 Italy bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 32 Spain bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 33 Spain bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 34 Spain bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 35 Denmark bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 36 Denmark bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 37 Denmark bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 38 Sweden bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 39 Sweden bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 40 Sweden bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 41 Norway bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 42 Norway bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 43 Norway bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 44 Asia Pacific bioprocess validation market by country, 2018 - 2030 (USD million)
Table 45 Asia Pacific bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 46 Asia Pacific bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 47 Asia Pacific bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 48 China bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 49 China bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 50 China bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 51 Japan bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 52 Japan bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 53 Japan bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 54 India bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 55 India bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 56 India bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 57 Australia bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 58 Australia bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 59 Australia bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 60 Thailand bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 61 Thailand bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 62 Thailand bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 63 South Korea bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 64 South Korea bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 65 South Korea bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 66 Latin America bioprocess validation market by country, 2018 - 2030 (USD million)
Table 67 Latin America bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 68 Latin America bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 69 Latin America bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 70 Brazil bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 71 Brazil bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 72 Brazil bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 73 Mexico bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 74 Mexico bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 75 Mexico bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 76 Argentina bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 77 Argentina bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 78 Argentina bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 79 Middle East & Africa bioprocess validation market by country, 2018 - 2030 (USD million)
Table 80 Middle East & Africa bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 81 Middle East & Africa bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 82 Middle East & Africa bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 83 South Africa bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 84 South Africa bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 85 South Africa bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 86 Saudi Arabia bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 87 Saudi Arabia bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 88 Saudi Arabia bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 89 UAE bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 90 UAE bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 91 UAE bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 92 Kuwait bioprocess validation market by testing type, 2018 - 2030 (USD million)
Table 93 Kuwait bioprocess validation market by stage, 2018 - 2030 (USD million)
Table 94 Kuwait bioprocess validation market by mode, 2018 - 2030 (USD million)
Table 95 Participant’s overview
Table 96 Financial performance
Table 97 Key companies undergoing expansions
Table 98 Key companies undergoing acquisitions
Table 99 Key companies undergoing collaborations
Table 100 Key companies launching new products/services
Table 101 Key companies undergoing partnerships
Table 102 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s Five Forces analysis
Fig. 14 SWOT analysis
Fig. 15 Bioprocess validation market: Testing type outlook and key takeaways
Fig. 16 Bioprocess validation market: Testing type movement analysis
Fig. 17 Global extractables & leachables testing market, 2018 - 2030 (USD Million)
Fig. 18 Global bioprocess residuals testing market, 2018 - 2030 (USD Million)
Fig. 19 Global viral clearance testing market, 2018 - 2030 (USD Million)
Fig. 20 Global filtration & fermentation systems testing market, 2018 - 2030 (USD Million)
Fig. 21 Bioprocess validation market: Stage outlook and key takeaways
Fig. 22 Bioprocess validation market: Stage movement analysis
Fig. 23 Global process design market, 2018 - 2030 (USD Million)
Fig. 24 Global process qualification market, 2018 - 2030 (USD Million)
Fig. 25 Global continued process verification market, 2018 - 2030 (USD Million)
Fig. 26 Global others market, 2018 - 2030 (USD Million)
Fig. 27 Bioprocess validation market: Mode outlook and key takeaways
Fig. 28 Bioprocess validation market: Mode movement analysis
Fig. 29 Global in-house market, 2018 - 2030 (USD Million)
Fig. 30 Global outsourced market, 2018 - 2030 (USD Million)
Fig. 31 Bioprocess validation market: Regional outlook and key takeaways
Fig. 32 North America: SWOT Analysis
Fig. 33 North America bioprocess validation market, 2018 - 2030 (USD Million)
Fig. 34 US key country dynamics
Fig. 35 US bioprocess validation market, 2018 - 2030 (USD Million)
Fig. 36 Canada key country dynamics
Fig. 37 Canada bioprocess validation market, 2018 - 2030 (USD Million)
Fig. 38 Europe: SWOT Analysis
Fig. 39 Europe bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 UK key country dynamics
Fig. 41 UK bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Germany key country dynamics
Fig. 43 Germany bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 France key country dynamics
Fig. 45 France bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Italy key country dynamics
Fig. 47 Italy bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Spain key country dynamics
Fig. 49 Spain bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Norway key country dynamics
Fig. 55 Norway bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Rest of Europe key country dynamics
Fig. 57 Rest of Europe bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Asia-Pacific: SWOT Analysis
Fig. 59 Asia-Pacific bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 China key country dynamics
Fig. 61 China bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Japan key country dynamics
Fig. 63 Japan bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 India key country dynamics
Fig. 65 India bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Australia key country dynamics
Fig. 67 Australia bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Thailand key country dynamics
Fig. 69 Thailand bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea key country dynamics
Fig. 71 South Korea bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Rest of Asia Pacific key country dynamics
Fig. 73 Rest of Asia Pacific bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Latin America: SWOT Analysis
Fig. 75 Latin America bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Brazil key country dynamics
Fig. 77 Brazil bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Mexico key country dynamics
Fig. 79 Mexico bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Argentina key country dynamics
Fig. 81 Argentina bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Rest of Latin America key country dynamics
Fig. 83 Rest of Latin America bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Middle East Asia: SWOT Analysis
Fig. 85 Middle East Asia bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 South Africa key country dynamics
Fig. 87 South Africa bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia key country dynamics
Fig. 89 Saudi Arabia bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 UAE key country dynamics
Fig. 91 UAE bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 Kuwait key country dynamics
Fig. 93 Kuwait bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Rest of Middle East & Africa key country dynamics
Fig. 95 Rest of Middle East & Africa bioprocess validation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 Heat map analysis
Fig. 97 Market participant categorization
Fig. 98 Bioprocess validation market share analysis, 2022
Fig. 99 Strategy framework
Companies Mentioned
- Eurofins Scientific, Inc.
- Sartorius Ag
- Thermo Fisher Scientific Inc.
- Lonza
- Danaher Corporation
- Charles River Laboratories
- Sgs S.A.
- Toxicon Corporation
- Epigenomics Ag
- Cobetter Filtration Equipment Co., Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | January 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 457.8 Million |
| Forecasted Market Value ( USD | $ 842.5 Million |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
